{
  "title": "Breakthrough, Part Seven: The Vaccine Race",
  "itunes:title": "Breakthrough, Part Seven: The Vaccine Race",
  "description": "<p>Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:season": 7,
  "itunes:episode": 7,
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "34f92f5c-51fc-11ec-b47d-971d34fccbac",
  "omny:clipId": "4a5bd8cd-6d6d-4c6e-be4d-ae3900817711",
  "pubDate": "Tue, 30 Nov 2021 16:54:00 +0000",
  "itunes:duration": 2121,
  "enclosure": "",
  "link": "https://www.bloomberg.com/prognosis"
}